Reason for request
Re-assessment of the actual benefit at the request of the Transparency
Clinical Benefit
| Low |
Le service médical rendu par MEGACE 160 mg est faible dans le traitement palliatif des carcinomes du sein.
|
eNq9mF1v2jAUhu/5FVHukzQUWpgC1cbaDalVGQVt2k1lkgOYGTv1Bx/79XMI3ejkqMPUu4oSO+858Xn9+CjJ1WZJvBVwgRnt+HF45ntAU5ZhOuv449FN0PKvurVkgVboYNpleBbGdd9LCRKi4xej4QQQFeG3u9uPoN8H7ndrXsImC0jli3lKYhJ+RmJ+h/JijpesGM68Jcg5yzp+ruTuqZcIyXUW3TXjP0SOUkii/ZPD0cVj4/B5EhVi/6CqBPBbRGdGUaBWmqniHKjsIQkzxrcV+Z5baWMxBMEUT2GA5HzA2QpnkBlDTBERYBVkus4egK8IyCKIUTxapEthJY4WaDOEp7456fd6tCc3MjgL4svmZdxq1c8b5422VSh+sFTmKuiPiNLH+KLRarfbEdBoCTNtsUBfQM9hJNB3UhcyyMCyXgPGJSKOKoVF76XZHMXh8PSqIzIscoK24ULktkuFONLDwDUS3H1I8QUjriFF9Jr9pU8VIdGRWY/3CHGUcUGoHlNUVpDkZmi7ED1GJWyqK2oHP7nZexGDeDvZn4yawT9QE4JTW8xpECm90cfDfjXlXAPiAxIw5u4I8RXTjK3F25PnsNKOss938DSK5jyLH+vt1kXcbFpvrO/aVhUn0bXiLIdIMwmLU1DTp1N2KmS0U81Szz51atFdj8RSRKCiSwosGaS9+dzUOXO/u51VDhhFP12PbC3zRQHfPuxujdI46/wuth2gXVBfG7Qy8ePtXu56J/2z4maazKXMxbsoWq/X4RyJQCC9SuGU/5cT4OAgdtfROznty+6npKij1Cfl8Xhc1Wx332v9wKk97v79fS9tjCG5ghNqUYLaGU77129P6D8NrrO0By+I4i7MrhlFEjPqqiFSE6PiaWeCriu94RoQ99MprvjDUunLJCr/7nRrSVT82enWfgH58wLj
svbusQ9X0v2NADx6
Listen
